NCT07019415Completed
Efect Supplementation Vitamin D in Diabetes Mellitus Type 2
Effect Supplementation Vitamin D on HbA1c, Insulin, HOMA-IR and VCAM-1 in Diabetes Mellitus Type 2
Source: ClinicalTrials.gov · Last updated 13 Jun 2025
Brief summary (registry, in English)
This is double blind randomized controlled trial study using 92 subject with diabetes mellitus type 2divided into 2 group, one group as control and other group as vitamin D group. At the end of study the study subject only left 40 subjects in each group. Vitamin D group received vitamin D 5000 IU and the control group received calcium carbonate, microcrystalline cellulose, magnesium stearate, sodium starch glycolate for 6 months. The goal of this study was to determine whether suplmentation Vitamin D 5000 IU for 6 months have any effect on HbA1c, insulin, HOMA-IR nd VCAM-1 in Diabetes mellitus type 2
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 92 (actual)
- First submitted
- 4 Jun 2025
- Start date
- 6 Aug 2024
- Primary completion date
- 28 Feb 2025
- Lead sponsor
- Trisakti University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07019415
What you commit to
- Study type: Interventional
- Participants enrolled: 92
- From 6 Aug 2024 to the primary completion date, 28 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- used insulin therapy
- had been consuming vitamin D in three months before the study.
Other illness
- had liver disease, renal disease
Other
- pregnant women, or breast feeding women
- alergy
- hypercalsemia
Who the study is looking for
- male and females age 18 - 65 years old
- had been diagnosed T2DM,
- duration T2DM ≤ 3 year
- HbA1c \> 6,5 %
- used single antidibetic
- were willing to follow the protocol of the study and were willing to participate in this study after receiving explanations, by signing informed consent.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Trisakti University Coordinator of this site? Confirm its status | Jakarta | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.